XM does not provide services to residents of the United States of America.

U.S. STOCKS Alnylam Pharmaceuticals, Emergent BioSolutions, Talos Energy



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Alnylam Pharmaceuticals, Emergent BioSolutions, Talos Energy</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street's main indexes were set for a higher start on Friday after a key inflation report reiterated that price pressures were moderating, cementing bets for an interest-rate cut at the Federal Reserve's upcoming meeting in September..N


At 9:04 ET, Dow e-minis 1YMc1 were up 0.09% at 41,477. S&P 500 e-minis ESc1 were up 0.30% at 5,626.75, while Nasdaq 100 e-minis NQc1 were up 0.67% at 19,523.75.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Emergent BioSolutions Inc EBS.N, up 15.8%
** Cool Company Ltd CLCO.N, up 8.8%
** Allurion Technologies Inc ALUR.N, up 8.1%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Elastic Nv ESTC.N, down 27.9%
** V2x Inc VVX.N, down 9%
** Solo Brands Inc DTC.N, down 7.8%

The top three Nasdaq percentage gainers premarket .PRPG.O:
** Agape Atp Corp ATPC.O, up 139.9%
** Mountain Crest Acquisition Corp MCAGR.O, up 143.5%
** Brenmiller Energy Ltd BNRG.O, up 128.6%

The top Nasdaq percentage loser premarket .PRPL.O:
** Nucana Plc NCNA.O, down 49.7%


** Emergent BioSolutions Inc EBS.N: up 15.8% premarket
BUZZ - Jumps on FDA nod for smallpox vaccine for high-risk mpox cases nL4N3KH0K9


** Intel Corp INTC.O: up 6.6% premarket
BUZZ - Rises on report of considering options to cope with slump nL4N3KH0LK


** Dell Technologies Inc DELL.N: up 5.3% premarket
BUZZ - Climbs after raising FY forecast on Nvidia-powered AI servers' demand nL4N3KH0LM


** Intuitive Machines Inc LUNR.O: up 22.0% premarket
BUZZ - Soars on $116.9 mln NASA contract nL4N3KH0MB


** Alibaba.com Ltd BABA.N: up 4.8% premarket
** JD.com Inc JD.O: up 4.0% premarket
** Pinduoduo Inc PDD.O: up 2.5% premarket
** Bilibili Inc BILI.O: up 3.7% premarket
BUZZ - China ADRs rise on state fund buying nL4N3KH0OS


** JinkoSolar Holding Co JKS.N: down 2.3% premarket
BUZZ - Slips on Q2 loss nL4N3KH0RR


** Smartsheet Inc SMAR.N: up 2.3% premarket
BUZZ - Guggenheim raises PT for Smartsheet; says can beat forecast throughout year nL4N3KH0SA


** Alnylam Pharmaceuticals Inc ALNY.O: down 8.0% premarket
BUZZ - Falls as heart drug trial data fails to impress nL4N3KH0TJ


** Talos Energy Inc TALO.N: down 2.8% premarket
BUZZ - Falls after CEO Tim Duncan steps down nL4N3KH0X3


(Compiled by Rajarshi Roy and Pooja Menon in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.